BRCA 1 /2 AND / OR HRD

Clinical trials for BRCA 1 /2 AND / OR HRD explained in plain language.

Never miss a new study

Get alerted when new BRCA 1 /2 AND / OR HRD trials appear

Sign up with your email to follow new studies for BRCA 1 /2 AND / OR HRD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New cancer drug combo enters human testing

Disease control Recruiting now

This early-stage study is testing the safety and initial effects of a new drug called SYN818 when given with an existing cancer drug, olaparib. It is for adults with advanced or metastatic solid tumors (like ovarian or breast cancer) that have specific genetic changes (BRCA mutat…

Matched conditions: BRCA 1 /2 AND / OR HRD

Phase: PHASE1 • Sponsor: Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

BRCA 1 /2 AND / OR HRD

Get alerted when new BRCA 1 /2 AND / OR HRD trials appear

New cancer drug combo enters human testing